Oncoplastic Breast Surgery Clinical Trial
— PICO7YOfficial title:
An Observational, Prospective Multicentre Clinical Study to Assess the Safety and Clinical Performance of a New Single-use Negative Pressure Wound Therapy System (PICO 7Y) for the Simultaneous Management of Bilateral Closed Incisions in Oncoplastic Breast Surgery Patients
Verified date | June 2022 |
Source | Smith & Nephew, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of the study is to assess the use of a wound dressing system called PICO7Y following a two-sided breast surgery. PICO7Y is a new dressing system made to treat two incisions/wounds at the same time, and the purpose of this study is to check how the dressing is working by looking at data on how well the dressing performs while you wear it and to check if doctors and patients are happy with it. PICO7Y is based on another dressing called PICO.
Status | Completed |
Enrollment | 40 |
Est. completion date | February 29, 2020 |
Est. primary completion date | February 29, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: - The subject must have understood and provided written informed consent (reference section 9.1) - Female subjects who must be at least eighteen (18) years of age. - Willing and able to make all required study visits. - Able to follow instructions. - Subjects must be undergoing, at the same time, both an oncoplastic breast surgery and a symmetrising breast reduction on the contralateral breast and have closed incisions that would benefit from NPWT. - Subjects whose incisions will fit comfortably within the area of the pad of the dressing sizes provided. Exclusion Criteria: - Contraindications (per the PICO 7Y IFU) or hypersensitivity to the use of the investigational product or their components (i.e., silicone adhesives and polyurethane films [direct contact with wound], acrylic adhesives [direct contact with skin], polyethylene fabrics and super-absorbent powders [polyacrylates]) within the dressing. - Subjects with skin features (e.g. tattoos, skin colour, pre-existing scarring) which in the opinion of the Investigator, will interfere with the study assessments. - Suspected or confirmed allergy to any of the components of the ancillary products should they be deemed required, e.g. in the case of SECURA No-sting barrier skin wipes for patients with fragile skin. - Subjects with a local infection, close or at the site of the incision, at the time of surgery - Subjects with incisions that are actively bleeding unless haemostasis has been achieved. - Subjects with a genetic or acquired disease capable of negatively impact the closed incision healing. - Subjects with a history of poor compliance with medical treatment. - Subjects who have participated previously in this clinical trial. - Subjects with a medical or physical condition that, in the opinion of the Investigator, would preclude safe subject participation in the study. - Individuals from vulnerable populations including pregnant women and adult females over 75 years. - Subjects who have received adjuvant chemotherapy within the last 30 days prior to surgery. - Patients who at the end of the surgery have only one breast operated. |
Country | Name | City | State |
---|---|---|---|
Netherlands | Academic Hospital Maastricht | Maastricht | |
United Kingdom | Queen Elizabeth Hospital | Birmingham | |
United Kingdom | Royal Free Hospital | London | |
United Kingdom | Whythenshawe Hospital | Manchester | |
United Kingdom | Nottingham Breast Institute | Nottingham |
Lead Sponsor | Collaborator |
---|---|
Smith & Nephew, Inc. |
Netherlands, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinical performance PICO 7Y NPWT system within 7 days of surgery | To assess clinical performance of the PICO 7Y NPWT system through its capacity to deliver negative pressure consistently at -80 mmHg, to both the reconstructed breast and the contralateral breast, during a period of 7 days. This will be measured by assessing the incision wound on Day 7, using CDC wound assessment criteria. Photographs will also be taken of the incision wound with treatment and after treatment. | within 7 days of surgery | |
Primary | Clinical performance PICO 7Y NPWT system | To assess clinical performance of the PICO 7Y NPWT system through its capacity to deliver negative pressure consistently at -80 mmHg, to both the reconstructed breast and the contralateral breast, during a period of 7 days. This will be measured by assessing the incision wound on Day 14 using CDC wound assessment criteria. Photographs will also be taken of the incision wound with treatment and after treatment. | within 14 days of surgery | |
Primary | Clinical performance PICO 7Y NPWT system within 30 days of surgery | To assess clinical performance of the PICO 7Y NPWT system through its capacity to deliver negative pressure consistently at -80 mmHg, to both the reconstructed breast and the contralateral breast, during a period of 7 days. This will be measured by assessing the incision wound on Day 30, using CDC wound assessment criteria. Photographs will also be taken of the incision wound with treatment and after treatment. | within 30 days of surgery | |
Primary | Safety of the PICO7Y NPWT system through number of Adverse Events, Device Deficiencies and Serious Adverse Events. | Safety will be assessed by reporting any Adverse Events or Device deficiencies, and any Serious adverse events. | 1 year | |
Secondary | Rate of successful healing at day 30 | via photographs of the wound incision taken at Day 0, Day 14, and Day 30 | up to Day 30 | |
Secondary | Clinician Acceptability | Assessed with the electronic Case Report Forms, questioning the clinician's acceptability of the device | 1 year | |
Secondary | Patient Acceptability | Assessed with the electronic Case Report Forms, questioning the patient's acceptability of the device | 1 year | |
Secondary | Ease of Application | Assessed with electronic Case Report Forms, questioning ease of application as well as questionnaires given to the participants. | 1 year | |
Secondary | Comfort | Assessing patient comfort during wear by measuring the Visual Analogue Score at day 0 and day 7. | up to Day 7 | |
Secondary | Ease of Removal | Assessed with electronic Case Report forms, questioning ease of removal as well as questionnaire. | 1 year | |
Secondary | Dressing Wear Time | Assessed with electronic Case Report Forms as well as patient-facing questionnaires. | 1 year | |
Secondary | Incidence of Surgical Site Complications | This will be measured by assessing the incision wound with CDC criteria at Day 0 to Day 30. | up to Day 30 | |
Secondary | Evaluate change in health-related quality of life | Assessed by using EQ-5D 5L questionnaires at Day 0, Day 14 and Day 30. | up to Day 30 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05179304 -
Aesthetic Outcomes of Oncoplastic Breast Surgery for Breast Cancer in the Upper Inner Quadrant
|
N/A |